Bioqual, Inc. (BIOQ)
USD 66.1
(-2.79%)
USD 66.1
(-2.79%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -12 Million USD | -252.24% |
| 2022 | 7.88 Million USD | -52.32% |
| 2021 | 16.54 Million USD | 139.77% |
| 2020 | 6.89 Million USD | 17.15% |
| 2019 | 5.88 Million USD | 163.95% |
| 2018 | -9.2 Million USD | 7.09% |
| 2017 | -9.91 Million USD | -13.64% |
| 2016 | -8.72 Million USD | -102.46% |
| 2015 | -4.3 Million USD | -68.94% |
| 2014 | -2.54 Million USD | -369.13% |
| 2013 | -543.5 Thousand USD | 88.78% |
| 2012 | -4.84 Million USD | 0.0% |
| 2010 | -2.71 Million USD | 13.75% |
| 2009 | -3.15 Million USD | 0.0% |
| 2006 | -2.79 Million USD | -24.12% |
| 2005 | -2.25 Million USD | -83.27% |
| 2004 | -1.22 Million USD | -1445.45% |
| 2003 | -79.47 Thousand USD | 84.9% |
| 2002 | -526.49 Thousand USD | 0.0% |
| 2000 | 308.81 Thousand USD | -66.77% |
| 1999 | 929.34 Thousand USD | 182.63% |
| 1998 | 328.81 Thousand USD | -19.68% |
| 1997 | 409.36 Thousand USD | -46.27% |
| 1996 | 761.82 Thousand USD | 314.67% |
| 1995 | 183.72 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -10.39 Million USD | 13.43% |
| 2023 Q2 | 6.59 Million USD | -41.5% |
| 2023 Q4 | -12 Million USD | -403.78% |
| 2023 Q1 | 11.27 Million USD | -0.48% |
| 2023 Q3 | 3.95 Million USD | -40.07% |
| 2022 Q4 | 11.32 Million USD | -25.14% |
| 2022 Q3 | 15.13 Million USD | -17.93% |
| 2022 FY | 11.32 Million USD | -31.51% |
| 2022 Q2 | 18.44 Million USD | -3.14% |
| 2022 Q1 | 19.03 Million USD | 15.09% |
| 2021 Q3 | 17.17 Million USD | 13.94% |
| 2021 Q4 | 16.54 Million USD | -3.72% |
| 2021 FY | 16.54 Million USD | 139.77% |
| 2021 Q1 | 5.82 Million USD | -15.53% |
| 2021 Q2 | 15.07 Million USD | 158.72% |
| 2020 Q1 | 7.83 Million USD | 159.9% |
| 2020 FY | 6.89 Million USD | 17.15% |
| 2020 Q2 | 5.39 Million USD | -31.15% |
| 2020 Q3 | 7.01 Million USD | 30.04% |
| 2020 Q4 | 6.89 Million USD | -1.66% |
| 2019 Q3 | 3.32 Million USD | -58.6% |
| 2019 Q1 | 6.14 Million USD | 166.7% |
| 2019 Q4 | 3.01 Million USD | -9.27% |
| 2019 FY | 5.88 Million USD | 163.95% |
| 2019 Q2 | 8.02 Million USD | 30.67% |
| 2018 Q2 | -8.29 Million USD | 18.54% |
| 2018 FY | -9.2 Million USD | 7.09% |
| 2018 Q4 | -9.2 Million USD | -9.27% |
| 2018 Q3 | -8.42 Million USD | -1.62% |
| 2018 Q1 | -10.17 Million USD | -2.71% |
| 2017 Q2 | -7.55 Million USD | 1.08% |
| 2017 Q4 | -9.91 Million USD | -22.05% |
| 2017 FY | -9.91 Million USD | -13.64% |
| 2017 Q3 | -8.12 Million USD | -7.45% |
| 2017 Q1 | -7.63 Million USD | 12.4% |
| 2016 Q2 | 6.66 Million USD | 213.56% |
| 2016 FY | -8.72 Million USD | -102.46% |
| 2016 Q1 | -5.86 Million USD | -36.27% |
| 2016 Q4 | -8.72 Million USD | 0.0% |
| 2015 Q4 | -4.3 Million USD | 4.61% |
| 2015 Q3 | -4.51 Million USD | -67.39% |
| 2015 Q2 | -2.69 Million USD | -36.41% |
| 2015 Q1 | -1.97 Million USD | 22.44% |
| 2015 FY | -4.3 Million USD | -68.94% |
| 2014 Q3 | -1.22 Million USD | -96.44% |
| 2014 FY | -2.54 Million USD | -369.13% |
| 2014 Q1 | -1.36 Million USD | -150.81% |
| 2014 Q4 | -2.54 Million USD | -107.53% |
| 2014 Q2 | -625.43 Thousand USD | 54.12% |
| 2013 Q2 | -5.3 Million USD | -18.08% |
| 2013 Q3 | -1.41 Million USD | 73.35% |
| 2013 Q4 | -543.5 Thousand USD | 61.56% |
| 2013 FY | -543.5 Thousand USD | 88.78% |
| 2013 Q1 | -4.49 Million USD | 7.24% |
| 2012 FY | -4.84 Million USD | 0.0% |
| 2012 Q4 | -4.84 Million USD | -18.67% |
| 2012 Q3 | -4.08 Million USD | 6.98% |
| 2012 Q2 | -4.38 Million USD | 0.0% |
| 2011 Q1 | -3.76 Million USD | -38.28% |
| 2010 FY | -2.71 Million USD | 13.75% |
| 2010 Q3 | -1.41 Million USD | 29.62% |
| 2010 Q4 | -2.71 Million USD | -92.81% |
| 2010 Q2 | -2 Million USD | 0.0% |
| 2009 Q4 | -3.15 Million USD | 0.0% |
| 2009 FY | -3.15 Million USD | 0.0% |
| 2006 Q1 | 34.88 Thousand USD | 101.55% |
| 2006 Q3 | -752.29 Thousand USD | -68.61% |
| 2006 FY | -2.79 Million USD | -24.12% |
| 2006 Q4 | -2.79 Million USD | -271.39% |
| 2006 Q2 | -446.18 Thousand USD | -1378.97% |
| 2005 FY | -2.25 Million USD | -83.27% |
| 2005 Q4 | -2.25 Million USD | 0.0% |
| 2004 FY | -1.22 Million USD | -1445.45% |
| 2003 FY | -79.47 Thousand USD | 84.9% |
| 2002 FY | -526.49 Thousand USD | 0.0% |
| 2001 Q2 | 424.36 Thousand USD | 19.33% |
| 2001 Q3 | 296.09 Thousand USD | -30.22% |
| 2001 Q1 | 355.62 Thousand USD | 15.16% |
| 2000 Q1 | 564.69 Thousand USD | -39.24% |
| 2000 Q4 | 308.81 Thousand USD | -53.64% |
| 2000 Q2 | 452.44 Thousand USD | -19.88% |
| 2000 FY | 308.81 Thousand USD | -66.77% |
| 2000 Q3 | 666.07 Thousand USD | 47.22% |
| 1999 Q2 | 846.79 Thousand USD | 0.0% |
| 1999 FY | 929.34 Thousand USD | 182.63% |
| 1999 Q4 | 929.34 Thousand USD | 12.69% |
| 1999 Q3 | 824.69 Thousand USD | -2.61% |
| 1998 FY | 328.81 Thousand USD | -19.68% |
| 1997 FY | 409.36 Thousand USD | -46.27% |
| 1996 FY | 761.82 Thousand USD | 314.67% |
| 1995 FY | 183.72 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | 644.293% |
| Arrayit Corporation | 1.05 Million USD | 1237.489% |
| Atlantic International Corp. | 236.49 Thousand USD | 5177.086% |
| Biocept, Inc. | -788 Thousand USD | -1423.744% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | 52904.015% |
| DermTech, Inc. | 17.65 Million USD | 168.017% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 97.903% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | -62.766% |
| iMD Companies, Inc. | 1.11 Million USD | 1175.988% |
| IDenta Corp. | 524.85 Thousand USD | 2387.713% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 256.058% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | -44449.959% |
| InVitro International | -313.14 Thousand USD | -3734.396% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | 866.779% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | -1683925.947% |
| Medical Imaging Corp. | 3.79 Million USD | 416.732% |
| NovelStem International Corp. | 3.52 Million USD | 440.962% |
| Optigenex Inc. | 8.93 Million USD | 234.398% |
| PharmChem, Inc. | -1.49 Million USD | -703.466% |
| Proteome Sciences plc | 14.57 Million USD | 182.391% |
| Response Genetics, Inc | -13.08 Million USD | 8.245% |
| Rennova Health, Inc. | 14.82 Million USD | 180.966% |
| RushNet, Inc. | 4.8 Million USD | 350.104% |
| ScreenPro Security Inc. | 135.58 Thousand USD | 8955.516% |
| Stella Diagnostics Inc. | 6.19 Million USD | 293.88% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | 772.894% |
| Todos Medical Ltd. | 38.31 Million USD | 131.339% |